Poorer Drinking Outcomes with Citalopram Treatment for Alcohol Dependence: A Randomized, Double-Blind, Placebo-Controlled Trial.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Alcoholism: Clinical and Experimental Research

• Publication date

  2015-09-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1111/acer.12802PMID 26208048
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Current status of co-occurring mood and substance use disorders: a new therapeutic target.

  2015cited by this paper
• Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: a randomized, double blind, placebo-controlled human laboratory study.

  2014cited by this paper
• Ninety-three cases of alcohol dependence following SSRI treatment

  2014cited by this paper
• Missing data in alcohol clinical trials: a comparison of methods.

  2013cited by this paper
• Structured Clinical Interview for DSM-III-R Personality Disorders

  2012cited by this paper
• Neuroendocrine assessment of serotonergic, dopaminergic, and noradrenergic functions in alcohol-dependent individuals.

  2012cited by this paper
• Sertraline delays relapse in recently abstinent cocaine-dependent patients with depressive symptoms.

  2012cited by this paper
• Citalopram versus other anti-depressive agents for depression.

  2012cited by this paper
• Post-treatment outcomes in a double-blind, randomized trial of sertraline for alcohol dependence.

  2012cited by this paper
• A randomized controlled trial of fluoxetine in the treatment of cocaine dependence among methadone-maintained patients.

  2011cited by this paper
• HOW TO IMPUTE INTERACTIONS, SQUARES, AND OTHER TRANSFORMED VARIABLES

  2009cited by this paper
• Substance Abuse Treatment, Prevention, and Policy Treatment of Alcohol Dependence in Patients with Co-morbid Major Depressive Disorder – Predictors for the Outcomes with Memantine and Escitalopram Medication

  2008cited by this paper
• Sertraline Treatment of Co-occurring Alcohol Dependence and Major Depression

  2006cited by this paper
• Association between concurrent depression and anxiety and six-month outcome of addiction treatment.

  2005cited by this paper
• Effects of fluvoxamine on a multiple schedule of ethanol- and food-maintained behavior in two rat strains

  2005cited by this paper
• Treatment outcomes in type A and B alcohol dependence 6 months after serotonergic pharmacotherapy.

  2004cited by this paper
• Efficacy of fluvoxamine in preventing relapse in alcohol dependence: a one-year, double-blind, placebo-controlled multicentre study with analysis by typology.

  2004cited by this paper
• Sertraline for the prevention of relapse in detoxicated alcohol dependent patients with a comorbid depressive disorder: a randomized controlled trial.

  2003cited by this paper
• Sertraline and Cognitive Behavioral Therapy for Depressed Alcoholics: Results of A Placebo-Controlled Trial

  2003cited by this paper
• The course of anxiety, depression and drinking behaviours after completed detoxification in alcoholics with and without comorbid anxiety and depressive disorders.

  2001cited by this paper
• Double-Blind Clinical Trial of Sertraline Treatment for Alcohol Dependence

  2001cited by this paper
• The role of selective serotonin reuptake inhibitors in reducing alcohol consumption.

  2001cited by this paper
• Fluoxetine versus placebo in depressed alcoholics: a 1-year follow-up study.

  2000cited by this paper
• Sertraline treatment for alcohol dependence: interactive effects of medication and alcoholic subtype.

  2000cited by this paper
• Axis I and Axis II disorders in alcoholics and drug addicts: fact or artifact?

  2000cited by this paper
• Variations in response to citalopram in men and women with alcohol dependence.

  2000cited by this paper
• The effect of depression on return to drinking: a prospective study.

  1998cited by this paper
• Beck Anxiety Inventory.

  1997cited by this paper
• Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial.

  1997cited by this paper
• Structured clinical interview for DSM-IV axis II personality disorders : SCID-II

  1997cited by this paper
• Comorbid psychiatric diagnosis predicts three-year outcomes in alcoholics: a posttreatment natural history study.

  1996cited by this paper
• A placebo-controlled, double-blind study of fluoxetine in severe alcohol dependence: adjunctive pharmacotherapy during and after inpatient treatment.

  1996cited by this paper
• Citalopram in the treatment of alcoholism: a double-blind placebo-controlled study.

  1996cited by this paper
• Five-year course of major depression: effects of comorbid alcoholism.

  1996cited by this paper
• Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics.

  1995cited by this paper
• Effect of citalopram on alcohol intake in heavy drinkers.

  1994cited by this paper
• Interviewer severity ratings and composite scores of the ASI: a further look.

  1994cited by this paper
• Naltrexone in the treatment of alcohol dependence.

  1992cited by this paper
• Effects of fluoxetine and ca-acetyl-homotaurinate on alcohol intake in familial and nonfamilial alcoholic patients

  1992cited by this paper
• Motivational Interviewing: Preparing People to Change Addictive Behavior

  1991cited by this paper
• Serotonin uptake blockers and the treatment of alcoholism.

  1989cited by this paper
• A Test of Missing Completely at Random for Multivariate Data with Missing Values

  1988cited by this paper
• Treatment with sertraline, a new serotonin uptake inhibitor, reduces voluntary ethanol consumption in rats.

  1988cited by this paper
• The serotonin uptake inhibitor citalopram attenuates ethanol intake

  1987cited by this paper
• Applications of the Beck Depression Inventory

  1986cited by this paper
• Coefficient alpha and the internal structure of tests

  1951cited by this paper

• Addiction spectrum disorder: a conceptual framework for comprehensive understanding of addictive disorders

  2026cites this paper
• Different Sensitivity to Ethanol and Sucrose in DAT and SERT Knockout Rats

  2025cites this paper
• Species differences in comorbid alcohol use disorder and major depressive disorder: A narrative review

  2025cites this paper
• A Call for Better Guidance and Treatments for Comorbid Postpartum Depression and Substance Use Disorders

  2025cites this paper
• Antidepressants in Alcohol Use Disorder: Balancing Evidence, Clinical Nuance, and the Risks of Deprescribing

  2025cites this paper
• Concerns regarding the recommendation against prescribing selective serotonin reuptake inhibitors in the Canadian guideline for the clinical management of high-risk drinking and alcohol use disorder

  2024cites this paper
• Trouble grave lié à l’utilisation d’alcool après l’instauration d’un traitement par inhibiteur sélectif du recaptage de la sérotonine

  2024cites this paper
• Ligne directrice canadienne pour la prise en charge clinique de la consommation d’alcool à risque élevé et du trouble d’utilisation de l’alcool

  2024influential citation
• Analyse de la position de la Ligne directrice canadienne sur les inhibiteurs sélectifs du recaptage de la sérotonine dans un contexte de trouble lié à l’usage d’alcool et de troubles de l’humeur et anxieux concomitants

  2024cites this paper
• Gestion des risques associés aux antidépresseurs chez les personnes ayant un trouble d’utilisation de l’alcool

  2024cites this paper
• Navigating the nuances of the Canadian guideline’s stance on selective serotonin reuptake inhibitors in concurrent alcohol use disorder and mood or anxiety disorders

  2024cites this paper
• Addressing the risks of antidepressants among people with alcohol use disorders

  2024cites this paper
• Nicotine receptor partial agonists for smoking cessation

  2023cites this paper
• Pharmacological strategies for the management of the antisocial personality disorder

  2023cites this paper
• Canadian guideline for the clinical management of high-risk drinking and alcohol use disorder

  2023cites this paper
• Severe alcohol use disorder after initiation of selective serotonin reuptake inhibitor therapy

  2023cites this paper
• Re-Purposing FDA-Approved Drugs for Opioid Use Disorder

  2023cites this paper
• Alcohol use disorder with comorbid anxiety disorder: a case report and focused literature review

  2022cites this paper
• The Effects of Citalopram and Thalamic Dopamine D2/3 Receptor Availability on Decision-Making and Loss Aversion in Alcohol Dependence

  2022cites this paper
• Selective serotonin reuptake inhibitors in the treatment of depression, anxiety, and post-traumatic stress disorder in substance use disorders: a Bayesian meta-analysis

  2022cites this paper
• A Novel Graphical Method for Data Presentation in Alcohol Systematic Reviews: The Interactive Harvest Plot.

  2021cites this paper
• Effects of Mindfulness-Based Interventions on Depressive Symptoms and Alcohol Craving in Individuals With Comorbid Alcohol Use Disorder and Depression: A Systematic Review.

  2021cites this paper
• Co-occurring Mood and Substance Use Disorders

  2020cites this paper
• The role of serotonin in alcohol use and abuse

  2020cites this paper
• Psychological therapies for people with borderline personality disorder.

  2020cites this paper
• Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments

  2020cites this paper
• Pharmacological interventions for antisocial personality disorder.

  2020cites this paper
• Unhelpful Prescribing in Alcohol Use Disorder: Risk and Averting Risk.

  2019cites this paper
• Bupropion, a possible antidepressant without negative effects on alcohol relapse.

  2019cites this paper
• Rethinking the Use of Antidepressants to Treat Alcohol Use Disorders and Depression Comorbidity: The Role of Neurogenesis

  2019cites this paper
• Association between alcoholic interventions and abstinence rates for alcohol use disorders

  2018cites this paper
• Personality Disorder and Alcohol Use Disorder: An Overview

  2018cites this paper
• Antidepressants for the treatment of people with co-occurring depression and alcohol dependence.

  2018cites this paper
• Management of Eating Disorders When There Is Also Substance Misuse

  2018cites this paper
• Personality disorder and alcohol treatment outcome: systematic review and meta-analysis

  2017cites this paper
• Serotonin Deficiency and Alcohol Use Disorders

  2017cites this paper
• Depression and Bipolar Disorders in Patients With Alcohol Use Disorders.

  2017cites this paper
• Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.

  2017cites this paper
• Alcohol use disorder and depression: proposed rewording of Choosing Wisely recommendation

  2017cites this paper
• Links between serotonin reuptake inhibition during pregnancy and neurodevelopmental delay/spectrum disorders: A systematic review of epidemiological and physiological evidence

  2016cites this paper
• Comparison of Neurocognition and Behavioral in Alcohol with Placebo group

  2016cites this paper
• Komorbidität affektiver Erkrankungen und alkoholbezogener Störungen

  2016influential citation
• Prescription for antidepressant in reducing future alcohol-related readmission in patients suffering from depression and alcohol use disorder: a retrospective medical record review

  2015cites this paper